Abstract
Guanylyl cyclases (GC) exist as soluble and particulate, membrane-associated enzymes which catalyse the conversion of GTP to cGMP, an intracellular signalling molecule. Several membrane forms of the enzyme have been identified up to now. Some of them serve as receptors for the natriuretic peptides, a family of peptides which includes atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP), three peptides known to play important roles in renal and cardiovascular physiology. These are transmembrane proteins composed of a single transmembrane domain, a variable extracellular natriuretic peptide-binding domain, and a more conserved intracellular kinase homology domain (KHD) and catalytic domain. GC-A, the receptor for ANP and BNP, also named natriuretic peptide receptor-A or -1 (NPR-A or NPR-1), has been studied widely. Its mode of activation by peptide ligands and mechanisms of regulation serve as prototypes for understanding the function of other particulate GC. Activation of this enzyme by its ligand is a complex process requiring oligomerization, ligand binding, KHD phosphorylation and ATP binding. Gene knockout and genetic segregation studies have provided strong evidence for the importance of GC-A in the regulation of blood pressure and heart and renal functions. GC-B is the main receptor for CNP, the latter having a more paracrine role at the vascular and venous levels. The structure and regulation of GC-B is similar to that of GC-A. This chapter reviews the structure and roles of GC-A and GC-B in blood pressure regulation and cardiac and renal pathophysiology.
Similar content being viewed by others
References
Hardman JG, Sutherland EW: Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3',5'-monophosphate from guanosine triphosphate. J Biol Chem 244: 6363–6370, 1969
Schultz G, Bohme E, Munske K: Guanyl cyclase. Determination of enzyme activity. Life Sci 8: 1323–1332, 1969
Garbers DL, Hardman JG, Rudolph FB: Kinetic analysis of sea urchin sperm guanylate cyclase. Biochemistry 13: 4166–4171, 1974
Kimura H, Murad F: Evidence for two different forms of guanylate cyclase in rat heart. J Biol Chem 249: 6910–6916, 1974
Garbers DL, Parks MA, Hardman JG: Characterization of particulate and soluble guanylate cyclases from rat lung. J Biol Chem 250: 374–381, 1975
Ramarao CS, Garbers DL: Receptor-mediated regulation of guanylate cyclase activity in spermatozoa. J Biol Chem 260: 8390–8396, 1985
De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28: 89–94, 1981
Hamet P, Tremblay J, Thibault G, Garcia R, Cantin M, Genest J: Effect of atrial natriuretic factor on metabolism of cGMP. Endocrinology 112: 289, 1983
Hamet P, Tremblay J, Pang SC, Garcia R, Thibault G, Gutkowska J, Cantin M, Genest J: Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun 123: 515–527, 1984
Waldman SA, Rapoport RM, Murad F: Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem 259: 14332–14334, 1984
Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM: Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci USA 81: 7661–7664, 1984
Tremblay J, Gerzer R, Vinay P, Pang SC, Beliveau R, Hamet P: The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase. FEBS Lett 181: 17–22, 1985
Kuno T, Andresen JW, Kamisaki Y, Waldman SA, Chang LY, Saheki S, Leitman DC, Nakane M, Murad F: Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J Biol Chem 261: 5817–5823, 1986
Paul AK, Marala RB, Jaiswal RK, Sharma RK: Coexistence of guanylate cyclase and atrial natriuretic factor receptor in a 180-kD protein. Science 235: 1224–1226, 1987
Meloche S, McNicoll N, Liu B, Ong H, de Lean A: Atrial natriuretic factor R1 receptor from bovine adrenal zona glomerulosa: Purification, characterization, and modulation by amiloride. Biochemistry 27: 8151–8158, 1988
Tremblay J, Gerzer R, Pang SC, Cantin M, Genest J, Hamet P: ANF stimulation of detergent-dispersed particulate guanylate cyclase from bovine adrenal cortex. FEBS Lett 194: 210–214, 1986
Schulz S, Green CK, Yuen PS, Garbers DL: Guanylyl cyclase is a heatstable enterotoxin receptor. Cell 63: 941–948, 1990
Mann EA, Jump ML, Wu J, Yee E, Giannella RA: Mice lacking the guanylyl cyclase C receptor are resistant to STa-induced intestinal secretion. Biochem Biophys Res Commun 239: 463–466, 1997
Fulle HJ, Vassar R, Foster DC, Yang RB, Axel R, Garbers DL: A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons. Proc Natl Acad Sci USA 92: 3571–3575, 1995
Goraczniak RM, Duda T, Sharma RK: A structural motif that defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic factor signalling. Biochem J 282: 533–537, 1992
Margulis A, Goraczniak RM, Duda T, Sharma RK, Sitaramayya A: Structural and biochemical identity of retinal rod outer segment membrane guanylate cyclase. Biochem Biophys Res Commun 194: 855–861, 1993
Yang RB, Foster DC, Garbers DL, Fulle HJ: Two membrane forms of guanylyl cyclase found in the eye. Proc Natl Acad Sci USA 92: 602–606, 1995
Schulz S, Wedel BJ, Matthews A, Garbers DL: The cloning and expression of a new guanylyl cyclase orphan receptor. J Biol Chem 273: 1032–1037, 1998
Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA: Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375–414, 2000
Kohno M, Ikeda M, Johchi M, Horio T, Yasunari K, Kurihara N, Takeda T: Interaction of PDGF and natriuretic peptides on mesangial cell proliferation and endothelin secretion. Am J Physiol 265: E673–E679, 1993
Itoh H, Pratt RE, Dzau VJ: Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 86: 1690–1697, 1990
Itoh H, Pratt RE, Ohno M, Dzau VJ: Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 19: 758–761, 1992
Cao L, Gardner DG: Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25: 227–234, 1995
Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 332: 78–81, 1988
Minamino N, Kangawa K, Matsuo H: Isolation and identification of high molecular weight brain natriuretic peptide in porcine cardiac atrium. Biochem Biophys Res Commun 157: 402–409, 1988
Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168: 863–870, 1990
Kojima M, Minamino N, Kangawa K, Matsuo H: Cloning and sequence analysis of cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett 276: 209–213, 1990
Lisy O, Jougasaki M, Heublein DM, Schirger JA, Chen HH, Wennberg PW, Burnett JC: Renal actions of synthetic dendroaspis natriuretic peptide. Kidney Int 56: 502–508, 1999
Inagami T, Misono KS, Fukumi H, Maki M, Tanaka I, Takayanagi R, Imada T, Grammer RT, Naruse M, Naruse K, Pandey KN, Parmentier M, Yasujima M, Abe K: Structure and physiological actions of rat atrial natriuretic factor. Hypertension 10 (suppl I): I113–I117, 1987
Schulz-Knappe P, Honrath U, Forssmann WG, Sonnenberg H: Endogenous natriuretic peptides: Effect on collecting duct function in rat kidney. Am J Physiol 259: F415–F418, 1990
Takayanagi R, Snajdar RM, Imada T, Tamura M, Pandey KN, Misono KS, Inagami T: Purification and characterization of two types of atrial natriuretic factor receptors from bovine adrenal cortex: Guanylate cyclase-linked and cyclase-free receptors. Biochem Biophys Res Commun 144: 244–250, 1987
Lowe DG, Chang MS, Hellmiss R, Chen E, Singh S, Garbers DL, Goeddel DV: Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J 8: 1377–1384, 1989
Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL: The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58: 1155–1162, 1989
Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV: Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341: 68–72, 1989
Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252: 120–123, 1991
Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA: Physiological role of silent receptors of atrial natriuretic factor. Science 238: 675–678, 1987
Anand-Srivastava MB, Franks DJ, Cantin M, Genest J: Atrial natriuretic factor inhibits adenylate cyclase activity. Biochem Biophys Res Commun 121: 855–862, 1984
Hirata M, Chang CH, Murad F: Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells. Biochim Biophys Acta 101: 346–351, 1989
Dubois SK, Kishimoto I, Lillis TO, Garbers DL: A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function. Proc Natl Acad Sci USA 97: 4369–4373, 2000
Yamaguchi M, Rutledge LJ, Garbers DL: The primary structure of the rat guanylyl cyclase A/atrial natriuretic peptide receptor gene. J Biol Chem 265: 20414–20420, 1990
Gardner DG, Schaufele F, Gardner DG: Sp1 dependence of natriuretic peptide receptor A gene transcription in rat aortic smooth muscle cells. Endocrinology 140: 1695–1701, 1999
Liang F, Schaufele F, Gardner DG: Functional interaction of NF-Y and Sp1 is required for type a natriuretic peptide receptor gene transcription. J Biol Chem 276: 1516–1522, 2001
Cao L, Wu J, Gardner DG: Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J Biol Chem 270: 24891–24897, 1995
Cao L, Chen SC, Humphreys MH, Gardner DG: Ligand-dependent regulation of NPR-A gene expression in inner medullary collecting duct cells. Am J Physiol 275: F119–F125, 1998
Kumar R, Grammatikakis N, Chinkers M: Regulation of the atrial natriuretic peptide receptor by heat shock protein 90 complexes. J Biol Chem 276: 11371–11375, 2001
Chinkers M, Garbers DL: The protein kinase domain of the ANP receptor is required for signaling. Science 245: 1392–1394, 1989
Hasegawa M, Hidaka Y, Wada A, Hirayama T, Shimonishi Y: The relevance of N-linked glycosylation to the binding of a ligand to guanylate cyclase C. Eur J Biochem 263: 338–346, 1999
Lowe DG, Fendly BM: Human natriuretic peptide receptor-A guanylyl cyclase. J Biol Chem 267: 21691–21697, 1992
Tremblay J, Huot C, Koch C, Potier M: Characterization of the functional domains of the natriuretic peptide receptor/guanylate cyclase by radiation inactivation. J Biol Chem 266: 8171–8175, 1991
Iwata T, Uchida-Mizuno K, Katafuchi T, Ito T, Hagiwara H, Hirose S: Bifunctional atrial natriuretic peptide receptor (type A) exists as a disulfide-linked tetramer in plasma membranes of bovine adrenal cortex. J Biochem (Tokyo) 110: 35–39, 1991
Chinkers M, Wilson EM: Ligand-independent oligomerization of natriuretic peptide receptors. J Biol Chem 267: 18589–18597, 1992
Lowe DG: Human natriuretic peptide receptor-A guanylyl cyclase is self-associated prior to hormone binding. Biochemistry 31: 10421–10425, 1992
Huo X, Abe T, Misono KS: Ligand binding-dependent limited proteolysis of the atrial natriuretic peptide receptor: Juxtamembrane hinge structure essential for transmembrane signal transduction. Biochemistry 38: 16941–16951, 1999
Potter LR, Hunter T: Identification and characterization of the phosphorylation sites of the guanylyl cyclase-linked natriuretic peptide receptors A and B. Methods 19: 506–520, 1999
Potter LR, Hunter T: A constitutively ‘phosphorylated’ guanylyl cyclase-linked atrial natriuretic peptide receptor mutant is resistant to desensitization. Mol Biol Cell 10: 1811–1820, 1999
Kurose H, Inagami T, Ui M: Participation of adenosine 5'-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor. FEBS Lett 219: 375–379, 1987
Chang CH, Jiang B, Douglas JG: Structural requirements of ATP for activation of basal and atrial natriuretic factor-stimulated guanylate cyclase in rat lung membranes. Eur J Pharmacol 189: 293–298, 1990
Gazzano H, Wu HI, Waldman SA: Adenine nucleotide regulation of particulate guanylate cyclase from rat lung. Biochim Biophys Acta 1077: 99–106, 1991
Chinkers M, Singh S, Garbers DL: Adenine nucleotides are required for activation of rat atrial natriuretic peptide receptor/guanylyl cyclase expressed in a baculovirus system. J Biol Chem 266: 4088–4093, 1991
Larose L, McNicoll N, Ong H, de Lean A: Allosteric modulation by ATP of the bovine adrenal natriuretic factor R1 receptor functions. Biochemistry 30: 8990–8995, 1991
Wong SK, Ma CP, Foster DC, Chen AY, Garbers DL: The guanylyl cyclase-A receptor transduces an atrial natriuretic peptide/ATP activation signal in the absence of other proteins. J Biol Chem 270: 30818–30822, 1995
Koller KJ, de Sauvage FJ, Lowe DG, Goeddel DV: Conservation of the kinase like regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biol 12: 2581–2590, 1992
Marala R, Duda T, Goraczniak RM, Sharma RK: Genetically tailored atrial natriuretic factor-dependent guanylate cyclase. Immunological and functional identity with 180 kDa membrane guanylate cyclase and ATP signaling site. FEBS Lett 296: 254–258, 1992
Duda T, Goraczniak RM, Sharma RK: Core sequence of ATP regulatory module in receptor guanylate cyclases. FEBS Lett 315: 143–148, 1993
Hanks SK, Quinn AM, Hunter T: The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241: 42–52, 1988
Thompson DK, Garbers DL: Dominant negative mutations of the guanylyl cyclase-A receptor. J Biol Chem 270: 425–430, 1995
Wilson EM, Chinkers M: Identification of sequences mediating guanylyl cyclase dimerization. Biochemistry 34: 4696–4701, 1995
Duda T, Sharma RK: ATP bimodal switch that regulates the ligand binding and signal transduction activities of the atrial natriuretic factor receptor guanylate cyclase. Biochem Biophys Res Commun 209: 286–292, 1995
Duda T, Sharma RK: ATP modulation of the ligand binding and signal transduction activities of the type C natriuretic peptide receptor guanylate cyclase. Mol Cell Biochem 152: 179–183, 1995
Jewett JRS, Koller KJ, Goeddel DV, Lowe DG: Hormonal induction of low affinity receptor guanylyl cyclase. EMBO J 12: 769–777, 1993
Rondeau JJ, McNicoll N, Gagnon J, Bouchard N, Ong H, de Lean A: Stoichiometry of the atrial natriuretic factor-R1 receptor complex in the bovine zona glomerulosa. Biochemistry 34: 2130–2136, 1995
Marala RB, Sitaramayya A, Sharma RK: Dual regulation of atrial natriuretic factor-dependent guanylate cyclase activity by ATP. FEBS Lett 281: 73–76, 1991
Duda T, Goraczniak RM, Sitaramayya A, Sharma RK: Cloning and expression of an ATP-regulated human retina C-type natriuretic factor receptor guanylate cyclase. Biochemistry 32: 1391–1395, 1993
Parkinson SJ, Carrithers SL, Waldman SA: Opposing adenine nucleotide-dependent pathways regulate guanylyl cyclase C in rat intestine. J Biol Chem 269: 22683–22690, 1994
Potter LR, Garbers DL: Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. J Biol Chem 267: 14531–14534, 1992
Potter LR, Garbers DL: Protein kinase C-dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation. J Biol Chem 269: 14636–14642, 1994
Koller KJ, Lipari MT, Goeddel DV: Proper glycosylation and phosphorylation of the type A natriuretic peptide receptor are required for hormone-stimulated guanylyl cyclase activity. J Biol Chem 268: 5997–6003, 1993
Potter LR, Hunter T: Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor. J Biol Chem 273: 15533–15539, 1998
Potter LR, Hunter T: Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor. Mol Cell Biol 18: 2164–2172, 1998
Simpson FO: Blood pressure and sodium intake. In: J.H. Laragh, B.M. Brenner (eds), Hypertension: Pathophysiology, Diagnosis and Management - Vol. I. Raven Press, New York, 1995, pp 273–282
Chamoux E, Breault L, Lehoux JG, Gallo-Payet N: Involvement of the angiotensin II type 2 receptor in apoptosis during human fetal adrenal gland development. J Clin Endocrinol Metab 84: 4722–4730, 1999
Duda T, Sharma RK: Regulation of guanylate cyclase activity by atrial natriuretic factor and protein kinase C. Mol Cell Biochem 93: 179–184, 1990
Chinkers M: Targeting of a distinctive protein serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor. Proc Natl Acad Sci USA 91: 11075–11079, 1994
Hirata Y, Hirose S, Takata S, Takagi Y, Matsubara H: Down-regulation of atrial natriuretic peptide receptor and cyclic GMP response in cultured rat vascular smooth muscle cells. Eur J Pharmacol 135: 439–442, 1987
Neuser D, Bellemann P: Receptor binding, cGMP stimulation and receptor desensitization by atrial natriuretic peptides in cultured A10 vascular smooth muscle cells. FEBS Lett 209: 347–351, 1986
Roubert P, Lonchampt MO, Chabrier PE, Plas P, Goulin J, Braquet P: Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun 148: 61–67, 1987
Hughes RJ, Struthers RS, Fong AM, Insel PA: Regulation of the atrial natriuretic peptide receptor on a smooth muscle cell. Am J Physiol 253: C809–C816, 1987
Cahill PA, Redmond EM, Keenan AK: Vascular atrial natriuretic factor receptor subtypes are not independently regulated by atrial peptides. J Biol Chem 265: 21896–21906, 1990
Schiffrin EL, St-Louis J, Hamet P, Garcia R: Vascular receptors for atrial natriuretic peptide in spontaneously hypertensive rats. In: B.M. Brenner, J.H. Laragh (eds), Progress in Atrial Peptide Research (American Society of Hypertension Symposium Series), Vol. 3. Raven Press, New York, 1990, pp 564–566
Pandey KN: Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor downregulation. Biochem J 288: 55–61, 1992
Hirata Y, Takata S, Takagi Y, Matsubara H, Omae T: Regulation of atrial natriuretic peptide receptors in cultured vascular smooth muscle cells of rat. Biochem Biophys Res Commun 138: 405–412, 1986
Rathinavelu A, Isom GE: Differential internalization and processing of atrial-natriuretic-factor B and C receptor in PC12 cells. Biochem J 276: 493–497, 1991
Pandey KN, Kumar R, Li M, Nguyen H: Functional domains and expression of truncated atrial natriuretic peptide receptor-A: The carboxylterminal regions direct the receptor internalization and sequestration in COS-7 cells. Mol Pharmacol 57: 259–267, 2000
Hirata Y, Tomita M, Takada S, Yoshimi H: Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP. Biochem Biophys Res Commun 128: 538–546, 1985
Fujio N, Gossard F, Bayard F, Tremblay J: Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-β1 in cultured aortic smooth muscle cells. Hypertension 23: 908–913, 1994
Hum D, Desjardins R, del Rocio Sanchez Garcia M, Devost D, Gossard F, Hamet P, Tremblay J: Characterization and localization of a cGMP response element in the guanylyl cyclase A (GC-A) promoter. 2002 (in press)
Kato J, Lanier Smith KL, Currie MG: Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells. J Biol Chem 266: 14681–14685, 1991
Zhang LM, Tao H, Newman WH: Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: Role of cGMP. Am J Physiol 264: H1753–H1759, 1993
Kishimoto I, Nakao K, Suga SI, Hosoda K, Yoshimasa T, Itoh H, Imura H: Downregulation of C-receptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells. Am J Physiol 265: H1373–H1379, 1993
Chen HH, Burnett JC Jr: C-type natriuretic peptide: The endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32 (suppl 3): S22–S28, 1998
Maack T: Role of atrial natriuretic factor in volume control. Kidney Int 49: 1732–1737, 1996
Zhang PL, Mackenzie HS, Troy JL, Brenner BM: Effects of natriuretic peptide receptor inhibition on remnant kidney function in rats. Kidney Int 46: 414–420, 1994
Sakamoto K, Kikkawa R, Haneda M, Shigeta Y: Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist. Diabetologia 38: 536–542, 1995
John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679–681, 1995
Krag S, Osterby R, Chai Q, Nielsen CB, Hermans C, Wogensen L: TGF-beta1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man. Lab Invest 80: 1855–1868, 2000
Kasahara M, Mukoyama M, Sugawara A, Makino H, Suganami T, Ogawa Y, Nakagawa M, Yahata K, Goto M, Ishibashi R, Tamura N, Tanaka I, Nakao K: Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. J Am Soc Nephrol 11: 1691–1701, 2000
Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, Smithies O: The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 96: 7403–7408, 1999
Conte G, Bellizzi V, Cianciaruso B, Minutolo R, Fuiano G, De Nicola L: Physiologic role and diuretic efficacy of atrial natriuretic peptide in health and chronic renal disease. Kidney Int Suppl 59: S28–S32, 1997
Maack T, Marion DN, Camargo MJF, Kleinert HD, Laragh JH, Vaughan ED, Atlas SA: Effects of auriculin (ANF) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 77: 1069–1075, 1984
Almeida FA, Suzuki M, Maack T: Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats. Life Sci 39: 1193–1199, 1986
Trippodo NC, Robl JA, Asaad MM, Fox M, Panchal BC, Schaeffer TR: Effects of omapatrilat in low, normal, and high renin experimental hypertension. Am J Hypertens 11: 363–372, 1998
Schultz KD, Schultz K, Schultz G: Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature 265: 750–751, 1977
Katsuki S, Murad F: Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol 13: 330–341, 1977
Katsuki S, Arnold WP, Murad F: Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical-activity of various tissues. J Cyclic Nucleotide Res 3: 239–247, 1977
Katsuki S, Arnold W, Mittal C, Murad F: Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3: 23–35, 1977
Lincoln TM: Effects of nitroprusside and 8-bromo-cyclic GMP on the contractile activity of the rat aorta. J Pharmacol Exp Ther 224-1: 100–107, 1983
Lincoln TM: Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 41: 479–502, 1989
Hardman JG: Cyclic nucleotides and regulation of vascular smooth muscle. J Cardiovasc Pharmacol 6 Suppl 4: S639–S645, 1984
Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun 177: 927–931, 1991
Murad F: Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78: 1–5, 1986
Cornwell TL, Lincoln TM: Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. J Biol Chem 264: 1146–1155, 1989
Lincoln TM, Cornwell TL: Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 28: 129–137, 1991
Dey NB, Boerth NJ, Murphy-Ullrich JE, Chang PL, Prince CW, Lincoln TM: Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. Circ Res 82: 139–146, 1998
Redondo J, Bishop JE, Wilkins MR: Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts. Br J Pharmacol 124: 1455–1462, 1998
Burnett JC Jr, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP, Opgenorth TJ, Reeder GS: Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231: 1145–1147, 1986
Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N: Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94: 14730–14735, 1997
Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M: Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97: 4239–4244, 2000
Masciotra S, Picard S, Deschepper CF: Cosegregation analysis in genetic crosses suggests a protective role for atrial natriuretic factor against ventricular hypertrophy. Circ Res 84: 1453–1458, 1999
Deschepper CF, Masciotra S, Zahabi A, Boutin-Ganache I, Picard S, Reudelhuber TL: Functional alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses. Circ Res 88: 223–228, 2001
Hutchinson HG, Trindade PT, Cunanan DB, Wu CF, Pratt RE: Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res 35: 158–167, 1997
Pedram A, Razandi M, Kehrl J, Levin ER: Natriuretic peptides inhibit G protein activation. Mediation through cross-talk between cyclic GMP-dependent protein kinase and regulators of G protein-signaling proteins. J Biol Chem 275: 7365–7372, 2000
Suhasini M, Li H, Lohmann SM, Boss GR, Pilz RB: Cyclic-GMPdependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway. Mol Cell Biol 18: 6983–6994, 1998
Erhardt P, Troppmair J, Rapp UR, Cooper GM: Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogenactivated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol 15: 5524–5530, 1995
Lemay J, Hou Y, Tremblay J, Hamet P, deBlois D: Angiotensin 1-converting enzyme activity and vascular sensitivity to angiotensin I in rat carotid artery. Eur J Pharmacol 394: 301–309, 2000
Furuya M, Aisaka T, Honbou N, Kawashima K, Ohno T, Tanaka S, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun 193: 248–253, 1993
Morishita R, Gibbons GH, Pratt RE, Tomita N, Kaneda Y, Ogihara T, Dzau VJ: Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. J Clin Invest 94: 824–829, 1994
Louzier V, Eddahibi S, Raffestin B, Deprez I, Adam M, Levame M, Eloit M, Adnot S: Adenovirus-mediated atrial natriuretic protein expression in the lung protects rats from hypoxia-induced pulmonary hypertension. Hum Gene Ther 12: 503–513, 2001
Hamet P, Pausova Z, Adarichev S, Adaricheva K, Tremblay J: Hypertension: Genes and environment. J Hypertens 16: 397–418, 1998
Cusson JR, Tremblay J, Larochelle P, Schiffrin EL, Gutkowska J, Hamet P: Clinical relationships of cyclic GMP. In: F. Murad (ed), Cyclic GMP: Synthesis, Metabolism, and Function. Academic Press, San Diego, 1994, pp 305–319
Cusson JR, Hamet P, Gutkowska J, Kuchel O, Genest J, Cantin M, Larochelle P: Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension. J Hypertens 5: 435–443, 1987
Pang SC, Hoang MC, Tremblay J, Cantin M, Garcia R, Genest J, Hamet P: Effect of natural and synthetic atrial natriuretic factor on arterial blood pressure, natriuresis and cyclic GMP excretion in spontaneously hypertensive rats. Clin Sci 69: 721–726, 1985
Cusson JR, Thibault G, Kuchel O, Hamet P, Cantin M, Larochelle P: Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension. J Human Hypertens 3: 89–96, 1989
Dahl LK, Heine M, Tassinari L: Effects of chronic excess salt ingestion - evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 115: 1173–1190, 1962
Dahl LK, Knudsen KD, Heine M, Leith GJ: Effects of chronic excess salt ingestion: Modification of experimental hypertension in rat by variations in the diet. Circ Res 22: 11–18, 1968
Snajdar RM, Rapp JP: Atrial natriuretic factor in Dahl rats - atrial content and renal and aortic responses. Hypertension 7: 775–782, 1985
Hirata Y, Ganguli M, Tobian L, Iwai J: Dahl S rats have increased natriuretic factor in atria but are markedly hyporesponsive to it. J Hypertens 6 (suppl I): I148–I155, 1984
Takayanagi R, Imada T, Grammer RT, Misono KS, Naruse M, Inagami T: Atrial natriuretic factor in spontaneously hypertensive rats: Concentration changes with the progression of hypertension and elevated formation of cyclic GMP. J Hypertens 4 (suppl 3): S303–S307, 1986
Marsh EA, Seymour AA, Haley AB, Whinnery MA, Napier MA, Nutt RF, Blaine EH: Renal and blood pressure responses to synthetic atrial natriuretic factor in spontaneously hypertensive rats. Hypertension 7: 386–391, 1985
Kurihara M, Gutkind JS, Saavedra JM: Alteration of atrial natriuretic peptide binding sites in spontaneously hypertensive rats. Am J Hypertens 1 (suppl): 12S–14S, 1988
Saito H, Inui KI, Matsukawa Y, Okano T, Maegawa H, Nakao K, Morii N, Imura H, Makino S, Hori R: Specific binding of atrial natriuretic polypeptide to renal basolateral membranes in spontaneously hypertensive rats (SHR) and stroke-prone SHR. Biochem Biophys Res Commun 137: 1079–1085, 1986
Swithers SE, Stewart RE, McCarty R: Binding sites for atrial natriuretic factor (ANF) in kidneys and adrenal glands of spontaneously hypertensive (SHR) rats. Life Sci 40: 1673–1681, 1987
Tremblay J, Huot C, Willenbrock RC, Bayard F, Gossard F, Fujio N, Koch C, Kuchel O, Debinski W, Hamet P: Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats. J Clin Invest 92: 2499–2508, 1993
Deng AY, Dene H, Rapp JP: Congenic strains for the blood pressure quantitative trait locus on rat chromosome 2. Hypertension 30: 199–202, 1997
Tremblay J, Dutil J, Hamet P, Deng AY: Dissection of rat chromosome 2 with congenic strains support the ANP-receptor, GC-A as a candidate gene of hypertension in the Dahl rat. J Hypertens 19 (suppl 2): S163, 2001
Lopez J, Wong SKF, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A: Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65–68, 1995
Kishimoto I, Dubois SK, Garbers DL: The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: Acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA 93: 6215–6219, 1996
Brandt RR, Wright RS, Redfield MM, Burnett JC Jr: Atrial natriuretic peptide in heart failure. J Am Coll Cardiol 22: 86A–92A, 1993
Pettersson A, Hedner J, Hedner T: Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure. Acta Physiol Scand 135: 487–492, 1989
Abassi Z, Haramati A, Hoffman A, Burnett JC Jr, Winaver J: Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am J Physiol 259: R84–R89, 1990
Abassi ZA, Kelly G, Golomb E, Klein H, Keiser HR: Losartan improves the natriuretic response to ANF in rats with high-output heart failure. J Pharmacol Exp Ther 268: 224–230, 1994
Yechieli H, Kahana L, Haramati A, Hoffman A, Winaver J: Regulation of renal glomerular and papillary ANP receptors in rats with experimental heart failure. Am J Physiol 265: F119–F125, 1993
Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-Oka T, Hanaoka F: Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 94: 13873–13878, 1997
Levin ER, Frank HJL, Chaudhari A, Kirschenbaum MA, Bandt A, Mills S: Decreased atrial natriuretic factor receptors and impaired cGMP generation in glomeruli from the cardiomyopathic hamster. Biochem Biophys Res Commun 159: 807–814, 1989
Tsunoda K, Mendelsohn FA, Sexton PM, Chai SY, Hodsman GP, Johnston CI: Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure. Circ Res 62: 155–161, 1988
Cachofeiro V, Schiffrin EL, Cantin M, Garcia R: Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: Correlation with the peptide biological effects. Cardiovasc Res 24: 843–850, 1990
Legault L, Cernacek P, Levy M: Attempts to alter the heterogeneous response to ANP in sodium-retaining caval dogs. Can J Physiol Pharmacol 70: 897–904, 1992
Bianchi C, Thibault G, Wrobel-Konrad E, de Lean A, Genest J, Cantin M: Atrial natriuretic factor binding sites in experimental congestive heart failure. Am J Physiol 257: F515–F523, 1989
Isnard R, Carayon A, Eurin J, Maistre G, Bouanani N, Barthelemy C, Crozatier B, Komajda M, Legrand JC: Glomerular atrial natriuretic factor receptors in experimental congestive heart failure. Am J Physiol 265: H923–H928, 1993
Garcia R, Bonhomme MC, Schiffrin EL: Divergent regulation of atrial natriuretic factor receptors in high-output heart failure. Am J Physiol 263: H1790–H1797, 1992
Cohen AM, Gelvan A, Winaver J, Kahna L, Floru S, Djaldetti M: Atrial natriuretic peptide in relative polycythemia and polycythemia vera. Haematologica 74: 351–353, 1989
Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV: Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252: 120–123, 1991
Canaan-Kuhl S, Jamison RL, Myers BD, Pratt RE: Identification of B-receptor for natriuretic peptide in human kidney. Endocrinology 130: 550–552, 1992
Mukaddam-Daher S, Gutkowska J, Tremblay J, Dam TV, Quillen EW Jr: Regulation of renal atrial natriuretic peptide receptors in pregnant sheep. Endocrinology 136: 4565–4571, 1995
Mukaddam-Daher S, Jankowski M, Dam TV, Quillen EW Jr, Gutkowska J: Renal atrial natriuretic factor receptors in hamster cardiomyopathy. Kidney Int 48: 1875–1885, 1995
Schiffrin EL: Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure. Clin Sci 74: 213–218, 1988
Strom TM, Weil J, Braun F, Stangl K, Timnik AM, Heim JM, Gerzer R: Binding sites for atrial natriuretic peptide on platelets in patients with congestive cardiomyopathy. Eur J Clin Invest 18: 524–528, 1988
Galla JH, Schneider G, Kotchen TA, Hayslett JP: Renin and aldosterone in the cardiomyopathic hamster in congestive heart failure. Endocrinology 101: 389–395, 1977
Lambert C, Larose P, Ong H, Gutkowska J, du Souich P: Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters. Res Commun Chem Pathol Pharmacol 50: 181–199, 1985
Quirion R, Dalpe M, de Lean A: Characterization, distribution, and plasticity of atrial natriuretic factor binding sites in brain. Can J Physiol Pharmacol 66: 280–287, 1988
Kubo SH, Atlas SA, Laragh JH, Cody RJ: Maintenance of forearm vasodilator action of atrial natriuretic factor in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 69: 1306–1309, 1992
Hirooka Y, Takeshita A, Imaizumi T, Suzuki S, Yoshida M, Ando S, Nakamura M: Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. Circulation 82: 147–153, 1990
Hirsch AT, Dzau VJ, Creager MA: Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance. Circulation 75: IV36–IV48, 1987
Vagnetti D, Secca T, Roscani C, Santarella B, Di Nardo P: Atrial natriuretic factor stimulation of particulate guanylate cyclase in the alveolar zone of hamster lung: A cytochemical study. Med Sci Res 19: 47–48, 1991
Mukaddam-Daher S, Tremblay J, Fujio N, Koch C, Jankowski M, Quillen EW, Gutkowska J: Alteration of lung atrial natriuretic peptide receptors in genetic cardiomyopathy. Am J Physiol 271: L38–L45, 1996
Imamura T, Ohnuma N, Iwasa F, Furuya M, Hayashi Y, Inomata N, Ishihara T, Noguchi T: Protective effect of alpha-human atrial natriuretic polypeptide (alpha-hANP) on chemical-induced pulmonary edema. Life Sci 42: 403–414, 1988
Lofton CE, Newman WH, Currie MG: Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMP. Biochem Biophys Res Commun 172: 793–799, 1990
Perreault T, Gutkowska J: Role of atrial natriuretic factor in lung physiology and pathology. Am J Respir Crit Care Med 151: 226–242, 1995
Brandt RR, Redfield MM, Aarhus LL, Lewicki JA, Burnett JC Jr: Clearance receptor-mediated control of atrial natriuretic factor in experimental congestive heart failure. Am J Physiol 266: R936–R943, 1994
Nussenzveig DR, Lewicki JA, Maack T: Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J Biol Chem 265: 20952–20958, 1990
Gutkowska J, Nemer M, Sole MJ, Drouin J, Sirois P: Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy. J Clin Invest 83: 1500–1504, 1989
Lin X, Hanze J, Heese F, Sodmann R, Lang RE: Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 77: 750–758, 1995
Tei M, Horie M, Makita T, Suzuki H, Hazama A, Okada Y, Kawai C: Atrial natriuretic peptide reduces the basal level of cytosolic free Ca2+ in guinea pig cardiac myocytes. Biochem Biophys Res Commun 167: 413–418, 1990
Brown LA, Nunez DJ, Wilkins MR: Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J Clin Invest 92: 2702–2712, 1993
Willenbrock RC, Tremblay J, Garcia R, Hamet P: Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats. J Clin Invest 83: 482–489, 1989
Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJF, Scarborough RM, Lewicki JA: Atrial natriuretic factor in normal subjects and heart failure patients - plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 78: 1362–1374, 1986
Davis D, Baily R, Zelis R: Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am J Physiol 254: E760–E766, 1988
Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN: Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49: 1659–1666, 1982
Saito Y, Nakao K, Morii N, Sugawara A, Shiono S, Yamada T, Itoh H, Sakamoto M, Kurahashi K, Fujiwara M, Imura H: Bay K 8644, a voltage-sensitive calcium channel agonist, facilitates secretion of atrial natriuretic polypeptide from isolated perfused rat hearts. Biochem Biophys Res Commun 138: 1170–1176, 1986
Burnett JC Jr: Vasopeptidase inhibition: A new concept in blood pressure management. J Hypertens Suppl 17: S37–S43, 1999
Rights and permissions
About this article
Cite this article
Tremblay, J., Desjardins, R., Hum, D. et al. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem 230, 31–47 (2002). https://doi.org/10.1023/A:1014260204524
Issue Date:
DOI: https://doi.org/10.1023/A:1014260204524